robert dreicer, md, describes the results of the javelin-100 bladder cancer trial
Published 4 years ago • 49 plays • Length 2:05Download video MP4
Download video MP3
Similar videos
-
19:31
the javelin bladder 100 phase iii trial results
-
19:31
the javelin bladder 100 phase iii trial results
-
2:12
matthew galsky, md, shares the design and outcomes of the javelin bladder 100 study
-
6:20
researcher comment: the javelin bladder 100 trial | thomas powles
-
0:56
dr. dreicer on the treatment of bladder cancer
-
32:30
bladder cancer and immunotherapy with dr. terence friedlander
-
3:11
the benefits of active surveillance | adam feldman
-
2:00
main causes of bladder cancer
-
2:00
robert dreicer, md, updates us on the role of cabazitaxel from the card study
-
2:59
javelin bladder 100: avelumab shows os benefit for bladder cancer
-
3:52
expert comment: the javelin bladder 100 study | elizabeth plimack
-
1:09
dr. apolo on updated javelin results of avelumab in urothelial carcinoma
-
3:37
avelin bladder 100: avelumab maintenance indicated as a soc for advanced urothelial carcinoma
-
1:33
petros grivas, md, phd, offers perspective on the javelin bladder 100 trial updated at esmo 2020
-
3:13
javelin bladder 100: duration of treatment-free interval
-
4:46
the future of bladder cancer research
-
1:12
javelin bladder 100: avelumab maintenance for metastatic or locally advanced bladder cancer
-
3:05
javelin bladder 100: 1l urothelial cancer updates
-
1:49
fda approval of durvalumab for bladder cancer
-
0:54
dr. balar on results of keynote-052 in urothelial cancer
-
2:16
exploratory analyses from javelin bladder 100
-
3:57
javelin bladder 100 trial: biomarkers for maintenance avelumab in metastatic urothelial cancer